Detection of low-load Epstein-Barr virus in blood samples by enriched recombinase aided amplification assay

• Published in: AMB Express 2022-06, Vol.12 (1), p.71-71, Article 71
• Main Authors: Li, Jing-yi, Chen, Xiao-ping, Tie, Yan-qing, Sun, Xiu-li, Zhang, Rui-qing, He, An-na, Nie, Ming-zhu, Fan, Guo-hao, Li, Feng-yu, Tian, Feng-yu, Shen, Xin-xin, Feng, Zhi-shan, Ma, Xue-jun
• Format: Article
• Language: English
• Subjects: Amplification; Assaying; Beads; Biomedical and Life Sciences; Biotechnology; Blood; Enrichment; Epstein-Barr virus; Life Sciences; Low viral load; M1 beads; Mannan; Mannose-binding lectin; Microbial Genetics and Genomics; Microbiology; Nucleic acids; Original; Original Article; Polymerase chain reaction; Protein A; Proteins; RAA; Recombinase; Sensitive detection; Viruses
• ISSN: 2191-0855; 2191-0855
• DOI: 10.1186/s13568-022-01415-9

Epstein-Barr virus (EBV), a common human γ-herpesvirus, infects more than 90% of adults worldwide. The purpose of this study was to establish a novel EBV detection method by combining the recombinase aided amplification (RAA) assay with an initial enrichment step that utilizes magnetic beads coated with a recombinant human mannan-binding lectin (rhMBL, M1 protein). An M1 protein–protein A magnetic bead complex (M1 beads) was prepared and used to achieve separation and enrichment of EBV from blood. After nucleic acid extraction, DNA was amplified by RAA. Using 388 whole blood samples and 1 serum sample, we explored the specificity, sensitivity and applicability of the newly developed detection method and compared it with commercial quantitative real-time polymerase chain reaction (qPCR) following M1 bead enrichment, traditional qPCR and traditional RAA. After enrichment, the positivity rate of EBV was increased from 15.94% to 17.74% by RAA ( P